Germany's Curevac was supposed to be a big player in COVID vaccinations. But now important tests have disappointed. With an efficacy rate of just 47 percent, a much hyped vaccine is not useful. The EU had already ordered 400 million doses.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
#CureVac #Vaccine #Coronavirus